The overwhelming value of most early-stage companies resides in their intellectual assets. However, senior managers of such companies usually have no idea how to value their inventions. This is unfortunate as the inability to value intangible assets puts companies at a severe disadvantage when trying to monetize their discoveries through capital raises, licensing, joint-ventures or sales. Inventors, investors, patentees, licensors and licensees must be able to articulate the value of their patents and emerging technologies. Otherwise, they will never receive the valuations that they deserve.